S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
- Status
- TERMINATED
- Phase
- PHASE3
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3